SELLAS Life Sciences

$3.51
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.39 (+12.34%) Today
-$0.04 (-1.12%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell SLS and other stocks, options, and ETFs commission-free!

About SLS

SELLAS Life Sciences Group, Inc. engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and ct-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY. The listed name for SLS is SELLAS Life Sciences Group, Inc. Common Stock.

CEO
Angelos M. Stergiou
Employees
5
Headquarters
New York, New York
Founded
2006
Market Cap
33.59M
Price-Earnings Ratio
Dividend Yield
Average Volume
256.99K
High Today
$3.59
Low Today
$3.13
Open Price
$3.17
Volume
547.01K
52 Week High
$4.89
52 Week Low
$1.46

Collections

SLS Earnings

-$2.90
-$1.93
-$0.97
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
-$0.53 per share

You May Also Like